DK0592446T3 - Fyldningsteknik til fremstilling af lægemiddelholdige liposomer - Google Patents

Fyldningsteknik til fremstilling af lægemiddelholdige liposomer

Info

Publication number
DK0592446T3
DK0592446T3 DK92904373.5T DK92904373T DK0592446T3 DK 0592446 T3 DK0592446 T3 DK 0592446T3 DK 92904373 T DK92904373 T DK 92904373T DK 0592446 T3 DK0592446 T3 DK 0592446T3
Authority
DK
Denmark
Prior art keywords
drug
membrane permeability
preparation
cationic
anionic
Prior art date
Application number
DK92904373.5T
Other languages
Danish (da)
English (en)
Inventor
Eric A Forssen
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0592446T3 publication Critical patent/DK0592446T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK92904373.5T 1991-07-03 1991-07-03 Fyldningsteknik til fremstilling af lægemiddelholdige liposomer DK0592446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1991/004807 WO1993000888A1 (fr) 1991-07-03 1991-07-03 Technique de remplissage permettant de preparer des liposomes contenant un medicament
EP92904373A EP0592446B1 (fr) 1991-07-03 1991-07-03 Technique de remplissage permettant de preparer des liposomes contenant un medicament

Publications (1)

Publication Number Publication Date
DK0592446T3 true DK0592446T3 (da) 1996-01-29

Family

ID=25676859

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92904373.5T DK0592446T3 (da) 1991-07-03 1991-07-03 Fyldningsteknik til fremstilling af lægemiddelholdige liposomer

Country Status (10)

Country Link
EP (1) EP0592446B1 (fr)
JP (1) JPH06511470A (fr)
AT (1) ATE128621T1 (fr)
AU (1) AU654835B2 (fr)
CA (1) CA2111593A1 (fr)
DE (1) DE69113640T2 (fr)
DK (1) DK0592446T3 (fr)
ES (1) ES2078034T3 (fr)
GR (1) GR3017836T3 (fr)
WO (1) WO1993000888A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714163A (en) * 1994-06-27 1998-02-03 Nexstar Pharmaceuticals, Inc. Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties
US5800833A (en) * 1995-02-27 1998-09-01 University Of British Columbia Method for loading lipid vesicles
WO1996032930A1 (fr) * 1995-04-18 1996-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Procede de chargement de medicaments dans des liposomes et composition
US5827532A (en) * 1997-01-31 1998-10-27 The Reagents Of The University Of California Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
CA2304096C (fr) * 1997-09-18 2003-09-09 Pacira Pharmaceuticals, Inc. Compositions anesthesiques de liposomes a liberation prolongee
US6120800A (en) * 1997-09-25 2000-09-19 Nexstar Pharmaceuticals, Inc. Vinca-alkaloid vesicles with enhanced efficacy and tumor targeting properties
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
JP4649841B2 (ja) * 2004-02-18 2011-03-16 コニカミノルタエムジー株式会社 リポソーム含有製剤の製造方法、およびリポソーム含有製剤
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
LT3173073T (lt) 2004-05-03 2025-01-10 Ipsen Biopharm Ltd. Liposomos, skirtos vaistų pristatymui
WO2006037230A1 (fr) 2004-10-06 2006-04-13 Bc Cancer Agency Liposomes permettant une meilleure retention du medicament, destines au traitement du cancer
US20150004219A1 (en) 2012-02-02 2015-01-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Stable liposomes for drug delivery
EP3115039B1 (fr) * 2015-07-09 2021-12-15 beniag GmbH Procede de fabrication d'un melange en fusion destine au transfert d'une molecule chargee dans et/ou a travers une membrane de lipide
EP4647126A3 (fr) 2015-10-16 2026-02-11 Ipsen Biopharm Ltd. Stabilisation de compositions pharmaceutiques de camptothecine
TWI728255B (zh) 2017-07-24 2021-05-21 國邑藥品科技股份有限公司 包含弱酸藥物之脂質體組成物及其用途
WO2020102605A1 (fr) * 2018-11-15 2020-05-22 The Regents Of The University Of California Fibres revêtues de vésicules et leurs procédés de fabrication et d'utilisation
NL2023066B1 (en) * 2019-05-03 2020-11-30 Curesupport Holding B V Stabilized liposomes
US12023394B2 (en) * 2020-05-05 2024-07-02 The Regents Of The University Of California Vesicle-coated fibers made from crosslinked lipids
WO2021225113A1 (fr) * 2020-05-08 2021-11-11 国立大学法人京都工芸繊維大学 Procédé de concentration d'espèces chimiques ioniques
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
EP4415713A4 (fr) 2021-10-14 2025-08-06 Pacira Pharmaceuticals Inc Formulations de liposomes multivésiculaires de bupivacaïne et leurs utilisations
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58981B1 (en) * 1985-10-15 1993-12-15 Vestar Inc Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
JP2880800B2 (ja) * 1989-06-22 1999-04-12 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド カプセル化方法

Also Published As

Publication number Publication date
ATE128621T1 (de) 1995-10-15
AU654835B2 (en) 1994-11-24
DE69113640T2 (de) 1996-03-07
JPH06511470A (ja) 1994-12-22
CA2111593A1 (fr) 1993-01-21
ES2078034T3 (es) 1995-12-01
DE69113640D1 (de) 1995-11-09
AU9178091A (en) 1993-02-11
WO1993000888A1 (fr) 1993-01-21
GR3017836T3 (en) 1996-01-31
EP0592446B1 (fr) 1995-10-04
EP0592446A1 (fr) 1994-04-20

Similar Documents

Publication Publication Date Title
DK0592446T3 (da) Fyldningsteknik til fremstilling af lægemiddelholdige liposomer
NZ304801A (en) Nanofiltration of concentrated aqueous salt solutions using pressure to change the concentration of one solute
Saija et al. Flavonoid-biomembrane interactions: a calorimetric study on dipalmitoylphosphatidylcholine vesicles
DE3476338D1 (en) Preparation of unilamellar large diameter liposomes, their pharmaceutical application in view of the encapsulation of the active principle for sustained release, and device therefor
ES2053678T3 (es) Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.
JPH11155962A5 (fr)
IE830572L (en) Osmotic drug delivery system
FI964083A0 (fi) Fusogeeniset liposomit ja menetelmät valmistaa ja käyttää niitä
ES8104720A1 (es) Un procedimiento para la preparacion de composiciones lipo- somicas de substancias activas grasosolubles
DK0616799T3 (da) Kosmetisk applikationssystem for salicylsyre og fremgangsmåde til fremstilling heraf
DK0477333T3 (da) Farmaceutiske præparater
CA2130828A1 (fr) Colorants non azoiques a base de naphtalimide et leur utilisation
AU7285987A (en) For facilitating the formation of lipid spherules dispersed in an aqueous phase and for improving their stability and their degree of encapsulation, and corresponding dispersions
NZ215608A (en) Controlled release device using sealed water-soluble glass capsule
AU4246296A (en) Methods and apparatus for making liposomes containing hydrophobic drugs
MA19358A1 (fr) Procede de production de structures de membranes de lipides
Järvisalo et al. Action of propranolol on mitochondrial functions—Effects on energized ion fluxes in the presence of valinomycin
FR2502626B1 (fr) Acides oxazaphosphorin-4-thio-alcanesulfoniques, leurs sels neutres, procede pour leur preparation et preparations pharmaceutiques qui les contiennent
NZ331051A (en) Instant release forms of gelled active substances
JPS5460281A (en) Apparatus for diffusing substance between two kinds of fluid through semipermeable membrane
US4478596A (en) Delivery system for physiologically active agents
KR850001688A (ko) 프럭토즈 1-6 디포스페이트를 함유하는 리포즘을 이용하는 치료제 조성물 및 그 제조방법
RU95112241A (ru) Способ коррекции побочных эффектов химиолучевой терапии
Woodbury Making synaptic vesicles fuse with lipid bilayers
Carnahan The blood-brain barrier: a review 1887-1973